Here's Today's Feel-Good Story:
A celery-seed-derived neuroprotectant drug has shown to be promising in effectiveness in stroke cases.
Patients experienced a 70% better chance of improved neurological and general living outcomes following a stroke with the medicine called butylphthalide, which is already approved for use in China to treat strokes. The FDA has not yet approved it.
“This is the first trial to show the benefit of using a medication that protects the brain from damage caused by a lack of oxygen to brain tissue. The medication was given to patients with acute ischemic stroke who were also receiving treatment to restore blood flow to the brain,” said Baixue Jia, M.D., co-author of the study.